Femasys Stock In The News

FEMY Stock  USD 1.57  0.17  12.14%   
Our overall analysis of Femasys' news coverage and content from conventional and social sources shows investors' bearish mood towards Femasys. The specific impact of Femasys news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Femasys' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Femasys headlines in addition to utilizing other, more conventional financial analysis modules. Check out Femasys Backtesting and Femasys Hype Analysis.
For more information on how to buy Femasys Stock please use our How to Invest in Femasys guide.

Femasys Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Femasys Announces FemBloc Delivery Syste...
https://www.globenewswire.com/news-release/2025/03/13/3042184/0/en/Femasys-Announces-FemBloc-Delivery-System-Approval-in-Europe-A-Significant-Step-Towards-FemBloc-Permanent-Birth-Control-Availability-as-the-First-Ever-Non-Surgical-Approach.html
 Neutral
Macroaxis News: globenewswire.com
Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials
https://www.globenewswire.com/news-release/2025/02/25/3032138/0/en/Femasys-Announces-Peer-Reviewed-Publication-of-Positive-Safety-and-Efficacy-Results-from-FemBloc-Permanent-Birth-Control-Clinical-Trials.html
 Bullish
Macroaxis News: globenewswire.com
Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control
https://www.globenewswire.com/news-release/2025/01/30/3018042/0/en/Femasys-Announces-Notices-of-Intention-to-Grant-for-Two-New-European-Patent-Applications-Covering-Use-of-FemBloc-Permanent-Birth-Control.html
 Neutral
Macroaxis News: globenewswire.com
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment
https://www.globenewswire.com/news-release/2025/01/16/3010771/0/en/Femasys-Announces-Notice-of-Allowance-for-New-U-S-Patent-Application-Covering-Use-of-FemaSeed-for-Female-Infertility-Treatment.html
 Bullish
Macroaxis News: globenewswire.com
Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer
https://www.globenewswire.com/news-release/2023/11/30/2788577/0/en/Femasys-Inc-Announces-the-Appointment-of-James-Liu-M-D-as-Chief-Medical-Officer.html
 Bullish
Yahoo News
30 Countries with the Lowest Median Age in the World
https://finance.yahoo.com/news/30-countries-lowest-median-age-222729819.html
 Neutral
Macroaxis News: globenewswire.com
Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch
https://www.globenewswire.com/news-release/2023/11/28/2786954/0/en/Femasys-Inc-Completes-Enrollment-of-FemaSeed-Pivotal-Trial-in-Support-of-Commercial-Launch.html
 Neutral
Macroaxis News: globenewswire.com
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech
https://www.globenewswire.com/news-release/2023/11/15/2780928/0/en/Femasys-Inc-Secures-Additional-Financing-with-Strategic-Investment-from-Investors-led-by-PharmaCyte-Biotech.html
 Bullish
Macroaxis News: globenewswire.com
Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/11/14/2779911/0/en/Femasys-Inc-Announces-Financial-Results-for-the-Third-Quarter-Ended-September-30-2023-and-Provides-Corporate-Update.html
 Bullish
Yahoo News
12 Best Stocks For Day Trading
https://finance.yahoo.com/news/12-best-stocks-day-trading-180239911.html
 Bullish

Femasys Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Femasys and other traded companies coverage with news coverage. We help investors stay connected with Femasys headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Femasys Stock performance. Please note that trading solely based on the Femasys hype is not for everyone as timely availability and quick action are needed to avoid losses.
Femasys' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Femasys investors visualize upcoming and past events in order to time the market based on Femasys noise-free hype analysis.
Femasys stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Femasys earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Femasys that are available to investors today. That information is available publicly through Femasys media outlets and privately through word of mouth or via Femasys internal channels. However, regardless of the origin, that massive amount of Femasys data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Femasys news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Femasys relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Femasys' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Femasys alpha.

Femasys Largest EPS Surprises

Earnings surprises can significantly impact Femasys' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-09
2024-03-31-0.19-0.170.0210 
2023-08-10
2023-06-30-0.19-0.22-0.0315 
2022-08-10
2022-06-30-0.25-0.220.0312 
2022-05-11
2022-03-31-0.21-0.24-0.0314 
2024-08-08
2024-06-30-0.1733-0.21-0.036721 
2023-11-14
2023-09-30-0.22-0.26-0.0418 
View All Earnings Estimates

Femasys Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Femasys Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
13th of March 2025
Femasys Announces FemBloc Delivery System Approval in Europe A Significant Step Towards .....
at gurufocus.com 
Yahoo News
25th of February 2025
Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from F...
at finance.yahoo.com 
news
11th of February 2025
Navigating the Competitive Landscape in Small-Cap Medical Technology
at kalkinemedia.com 
Google News at Macroaxis
5th of February 2025
Femasys gains approvals for infertility and diagnostic products in Israel - Yahoo Finance
at news.google.com 
Gurufocus Stories at Macroaxis
30th of January 2025
Femasys Announces Notices of Intention to Grant for Two New European Patent Applications ....
at gurufocus.com 
Macroaxis News
29th of January 2025
Acquisition by Lee-sepsick Kathy of 59849 shares of Femasys at 1.17 subject to Rule 16b-3
at MacroaxisInsider 
Gurufocus Stories at Macroaxis
16th of January 2025
Symbol Lookup
at gurufocus.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Femasys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Femasys' short interest history, or implied volatility extrapolated from Femasys options trading.

Additional Tools for Femasys Stock Analysis

When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.